Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 104

1.

INNATE IMMUNITY IN NEPHROTOXIC ACUTE KIDNEY INJURY.

Reeves WB.

Trans Am Clin Climatol Assoc. 2019;130:33-40.

2.

Effects of General Anesthesia on 2 Urinary Biomarkers of Kidney Injury-Hepatitis A Virus Cellular Receptor 1 and Lipocalin 2-in Male C57BL/6J Mice.

Gibbs KM, Izer JM, Reeves WB, Wilson RP, Cooper TK.

J Am Assoc Lab Anim Sci. 2019 Jan 1;58(1):21-29. doi: 10.30802/AALAS-JAALAS-18-000062. Epub 2018 Dec 11.

3.

Definition, Management, and Outcomes of Acute Kidney Injury: An International Survey of Nephrologists.

Farooq U, Tober A, Chinchilli V, Reeves WB, Ghahramani N.

Kidney Dis (Basel). 2017 Dec;3(3):120-126. doi: 10.1159/000478264. Epub 2017 Aug 3.

4.

Neutrophil peptidyl arginine deiminase-4 has a pivotal role in ischemia/reperfusion-induced acute kidney injury.

Raup-Konsavage WM, Wang Y, Wang WW, Feliers D, Ruan H, Reeves WB.

Kidney Int. 2018 Feb;93(2):365-374. doi: 10.1016/j.kint.2017.08.014. Epub 2017 Oct 20.

5.

Calorimetric Biosensing System for Quantification of Urinary Creatinine.

Gaddes D, Reeves WB, Tadigadapa S.

ACS Sens. 2017 Jun 23;2(6):796-802. doi: 10.1021/acssensors.7b00161. Epub 2017 May 31.

PMID:
28723128
6.

Neutrophils in cisplatin AKI-mediator or marker?

Tadagavadi R, Reeves WB.

Kidney Int. 2017 Jul;92(1):11-13. doi: 10.1016/j.kint.2017.03.023.

PMID:
28646989
7.

Arginase-2 mediates renal ischemia-reperfusion injury.

Raup-Konsavage WM, Gao T, Cooper TK, Morris SM Jr, Reeves WB, Awad AS.

Am J Physiol Renal Physiol. 2017 Aug 1;313(2):F522-F534. doi: 10.1152/ajprenal.00620.2016. Epub 2017 May 17. Retraction in: Am J Physiol Renal Physiol. 2017 Oct 1;313(4):F1060.

8.

The sweetest thing: blocking fructose metabolism to prevent acute kidney injury?

Wyatt CM, Reeves WB.

Kidney Int. 2017 May;91(5):998-1000. doi: 10.1016/j.kint.2017.03.004.

9.

Emerging Cytokine Biosensors with Optical Detection Modalities and Nanomaterial-Enabled Signal Enhancement.

Singh M, Truong J, Reeves WB, Hahm JI.

Sensors (Basel). 2017 Feb 22;17(2). pii: E428. doi: 10.3390/s17020428. Review.

10.

Podocyte-specific chemokine (C-C motif) receptor 2 overexpression mediates diabetic renal injury in mice.

You H, Gao T, Raup-Konsavage WM, Cooper TK, Bronson SK, Reeves WB, Awad AS.

Kidney Int. 2017 Mar;91(3):671-682. doi: 10.1016/j.kint.2016.09.042. Epub 2016 Dec 1.

11.

Storage Time and Urine Biomarker Levels in the ASSESS-AKI Study.

Liu KD, Siew ED, Reeves WB, Himmelfarb J, Go AS, Hsu CY, Bennett MR, Devarajan P, Ikizler TA, Kaufman JS, Kimmel PL, Chinchilli VM, Parikh CR; ASSESS-AKI Study Investigators.

PLoS One. 2016 Oct 27;11(10):e0164832. doi: 10.1371/journal.pone.0164832. eCollection 2016.

12.

Of mice and women: do sex-dependent responses to ischemia-reperfusion injury in rodents have implications for delayed graft function in humans?

Wyatt CM, Coates PT, Reeves WB.

Kidney Int. 2016 Jul;90(1):10-3. doi: 10.1016/j.kint.2016.05.008.

PMID:
27312438
13.

Ultratrace level determination and quantitative analysis of kidney injury biomarkers in patient samples attained by zinc oxide nanorods.

Singh M, Alabanza A, Gonzalez LE, Wang W, Reeves WB, Hahm JI.

Nanoscale. 2016 Feb 28;8(8):4613-22. doi: 10.1039/c5nr08706f.

14.

Remote calorimetric detection of urea via flow injection analysis.

Gaddes DE, Demirel MC, Reeves WB, Tadigadapa S.

Analyst. 2015 Dec 7;140(23):8033-40. doi: 10.1039/c5an01306b.

15.

Dendritic Cell Protection from Cisplatin Nephrotoxicity Is Independent of Neutrophils.

Tadagavadi RK, Gao G, Wang WW, Gonzalez MR, Reeves WB.

Toxins (Basel). 2015 Aug 19;7(8):3245-56. doi: 10.3390/toxins7083245.

16.

NODding off in acute kidney injury with progranulin?

Tadagavadi RK, Reeves WB.

Kidney Int. 2015 May;87(5):873-5. doi: 10.1038/ki.2015.14.

17.

TRPM2 mediates ischemic kidney injury and oxidant stress through RAC1.

Gao G, Wang W, Tadagavadi RK, Briley NE, Love MI, Miller BA, Reeves WB.

J Clin Invest. 2014 Nov;124(11):4989-5001. doi: 10.1172/JCI76042. Epub 2014 Oct 8.

18.

Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways.

Lin L, Jin Y, Mars WM, Reeves WB, Hu K.

Am J Pathol. 2014 Oct;184(10):2757-67. doi: 10.1016/j.ajpath.2014.06.013. Epub 2014 Aug 12.

19.

Urine stability studies for novel biomarkers of acute kidney injury.

Parikh CR, Butrymowicz I, Yu A, Chinchilli VM, Park M, Hsu CY, Reeves WB, Devarajan P, Kimmel PL, Siew ED, Liu KD; ASSESS-AKI Study Investigators.

Am J Kidney Dis. 2014 Apr;63(4):567-72. doi: 10.1053/j.ajkd.2013.09.013. Epub 2013 Nov 5.

20.

Management of Diabetic Nephropathy in the Elderly: Special Considerations.

Abdel-Rahman EM, Alhamad T, Reeves WB, Awad AS.

J Nephrol Ther. 2012 Oct;2(5). pii: 124.

21.

Protective role of small pigment epithelium-derived factor (PEDF) peptide in diabetic renal injury.

Awad AS, Gao T, Gvritishvili A, You H, Liu Y, Cooper TK, Reeves WB, Tombran-Tink J.

Am J Physiol Renal Physiol. 2013 Sep 15;305(6):F891-900. doi: 10.1152/ajprenal.00149.2013. Epub 2013 Jul 24.

22.

Therapeutic Modalities in Diabetic Nephropathy: Future Approaches.

Reeves WB, Rawal BB, Abdel-Rahman EM, Awad AS.

Open J Nephrol. 2012 Jun 25;2(2):5-18.

23.

TNF-α mediates increased susceptibility to ischemic AKI in diabetes.

Gao G, Zhang B, Ramesh G, Betterly D, Tadagavadi RK, Wang W, Reeves WB.

Am J Physiol Renal Physiol. 2013 Mar 1;304(5):F515-21. doi: 10.1152/ajprenal.00533.2012. Epub 2013 Jan 2.

24.

Mechanisms of Cisplatin nephrotoxicity.

Miller RP, Tadagavadi RK, Ramesh G, Reeves WB.

Toxins (Basel). 2010 Nov;2(11):2490-518. doi: 10.3390/toxins2112490. Epub 2010 Oct 26. Review.

25.

Therapeutic modalities in diabetic nephropathy: standard and emerging approaches.

Abdel-Rahman EM, Saadulla L, Reeves WB, Awad AS.

J Gen Intern Med. 2012 Apr;27(4):458-68. doi: 10.1007/s11606-011-1912-5. Epub 2011 Oct 18. Review.

26.

Villin and actin in the mouse kidney brush-border membrane bind to and are degraded by meprins, an interaction that contributes to injury in ischemia-reperfusion.

Ongeri EM, Anyanwu O, Reeves WB, Bond JS.

Am J Physiol Renal Physiol. 2011 Oct;301(4):F871-82. doi: 10.1152/ajprenal.00703.2010. Epub 2011 Jul 27.

27.

Endogenous IL-10 attenuates cisplatin nephrotoxicity: role of dendritic cells.

Tadagavadi RK, Reeves WB.

J Immunol. 2010 Oct 15;185(8):4904-11. doi: 10.4049/jimmunol.1000383. Epub 2010 Sep 15.

28.

The assessment, serial evaluation, and subsequent sequelae of acute kidney injury (ASSESS-AKI) study: design and methods.

Go AS, Parikh CR, Ikizler TA, Coca S, Siew ED, Chinchilli VM, Hsu CY, Garg AX, Zappitelli M, Liu KD, Reeves WB, Ghahramani N, Devarajan P, Faulkner GB, Tan TC, Kimmel PL, Eggers P, Stokes JB; Assessment Serial Evaluation, and Subsequent Sequelae of Acute Kidney Injury Study Investigators.

BMC Nephrol. 2010 Aug 27;11:22. doi: 10.1186/1471-2369-11-22.

29.

tPA activates LDL receptor-related protein 1-mediated mitogenic signaling involving the p90RSK and GSK3beta pathway.

Lin L, Bu G, Mars WM, Reeves WB, Tanaka S, Hu K.

Am J Pathol. 2010 Oct;177(4):1687-96. doi: 10.2353/ajpath.2010.100213. Epub 2010 Aug 19.

30.

Impact of computerized order entry and pre-mixed dialysis solutions for continuous veno-venous hemodiafiltration on selection of therapy for acute renal failure.

Saadulla L, Reeves WB, Irey B, Ghahramani N.

J Med Syst. 2012 Feb;36(1):223-31. doi: 10.1007/s10916-010-9471-6. Epub 2010 Mar 26.

PMID:
20703723
31.

Quantitative analysis of creatinine in urine by metalized nanostructured parylene.

Wang H, Malvadkar N, Koytek S, Bylander J, Reeves WB, Demirel MC.

J Biomed Opt. 2010 Mar-Apr;15(2):027004. doi: 10.1117/1.3369002.

32.

Renal dendritic cells ameliorate nephrotoxic acute kidney injury.

Tadagavadi RK, Reeves WB.

J Am Soc Nephrol. 2010 Jan;21(1):53-63. doi: 10.1681/ASN.2009040407. Epub 2009 Oct 29.

33.

Netrin-1 overexpression protects kidney from ischemia reperfusion injury by suppressing apoptosis.

Wang W, Reeves WB, Pays L, Mehlen P, Ramesh G.

Am J Pathol. 2009 Sep;175(3):1010-8. doi: 10.2353/ajpath.2009.090224. Epub 2009 Aug 21.

34.

Netrin-1 increases proliferation and migration of renal proximal tubular epithelial cells via the UNC5B receptor.

Wang W, Reeves WB, Ramesh G.

Am J Physiol Renal Physiol. 2009 Apr;296(4):F723-9. doi: 10.1152/ajprenal.90686.2008. Epub 2009 Feb 11.

35.

Meprin A metalloproteases enhance renal damage and bladder inflammation after LPS challenge.

Yura RE, Bradley SG, Ramesh G, Reeves WB, Bond JS.

Am J Physiol Renal Physiol. 2009 Jan;296(1):F135-44. doi: 10.1152/ajprenal.90524.2008. Epub 2008 Oct 29.

36.

Association between increased body mass index, calcineurin inhibitor use, and renal graft survival.

Ghahramani N, Reeves WB, Hollenbeak C.

Exp Clin Transplant. 2008 Sep;6(3):199-202.

37.

Ultrasensitive detection of cytokines enabled by nanoscale ZnO arrays.

Adalsteinsson V, Parajuli O, Kepics S, Gupta A, Reeves WB, Hahm JI.

Anal Chem. 2008 Sep 1;80(17):6594-601. doi: 10.1021/ac800747q. Epub 2008 Aug 6.

PMID:
18681455
38.

TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.

Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB.

J Am Soc Nephrol. 2008 May;19(5):923-32. doi: 10.1681/ASN.2007090982. Epub 2008 Feb 6.

39.

Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury.

Reeves WB, Kwon O, Ramesh G.

Am J Physiol Renal Physiol. 2008 Apr;294(4):F731-8. doi: 10.1152/ajprenal.00507.2007. Epub 2008 Jan 30.

40.

Netrin-1 and kidney injury. I. Netrin-1 protects against ischemia-reperfusion injury of the kidney.

Wang W, Reeves WB, Ramesh G.

Am J Physiol Renal Physiol. 2008 Apr;294(4):F739-47. doi: 10.1152/ajprenal.00508.2007. Epub 2008 Jan 23.

41.

Targeted disruption of the meprin metalloproteinase beta gene protects against renal ischemia-reperfusion injury in mice.

Bylander J, Li Q, Ramesh G, Zhang B, Reeves WB, Bond JS.

Am J Physiol Renal Physiol. 2008 Mar;294(3):F480-90. doi: 10.1152/ajprenal.00214.2007. Epub 2008 Jan 2.

42.

Endotoxin and cisplatin synergistically induce renal dysfunction and cytokine production in mice.

Ramesh G, Zhang B, Uematsu S, Akira S, Reeves WB.

Am J Physiol Renal Physiol. 2007 Jul;293(1):F325-32. Epub 2007 May 9.

43.

Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-alpha produced by renal parenchymal cells.

Zhang B, Ramesh G, Norbury CC, Reeves WB.

Kidney Int. 2007 Jul;72(1):37-44. Epub 2007 Mar 28.

44.

Endotoxin and cisplatin synergistically stimulate TNF-alpha production by renal epithelial cells.

Ramesh G, Kimball SR, Jefferson LS, Reeves WB.

Am J Physiol Renal Physiol. 2007 Feb;292(2):F812-9. Epub 2006 Oct 10.

45.

p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice.

Ramesh G, Reeves WB.

Am J Physiol Renal Physiol. 2005 Jul;289(1):F166-74. Epub 2005 Feb 8.

46.

Inflammatory cytokines in acute renal failure.

Ramesh G, Reeves WB.

Kidney Int Suppl. 2004 Oct;(91):S56-61.

PMID:
15461705
47.
48.

TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure.

Ramesh G, Reeves WB.

Am J Physiol Renal Physiol. 2003 Oct;285(4):F610-8. Epub 2003 Jul 15.

49.
50.

Chloride channels in the loop of Henle.

Reeves WB, Winters CJ, Andreoli TE.

Annu Rev Physiol. 2001;63:631-45. Review.

PMID:
11181970

Supplemental Content

Loading ...
Support Center